An abandoned weight-loss drug gets a makeover

Remember the experimental weight-loss drug rimonabant, touted as a potential "miracle pill" that could help obese smokers kick the habit, lose weight and keep it off for two years? Marketed in Europe as Acomplia, the drug made it well into the U.S. Food and Drug Administration's approval process before it was linked in 2008 to a doubling of depression risk in those taking it. The drug ended up withdrawn from the European... [via Booster Shots]